Denali Therapeutics (DNLI) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Denali Therapeutics (DNLI) over the last 9 years, with Q3 2025 value amounting to -$49.4 million.
- Denali Therapeutics' Other Gross PP&E Adjustments fell 2781.96% to -$49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.4 million, marking a year-over-year decrease of 2781.96%. This contributed to the annual value of $2.0 million for FY2024, which is 8393.41% down from last year.
- Denali Therapeutics' Other Gross PP&E Adjustments amounted to -$49.4 million in Q3 2025, which was down 2781.96% from -$47.4 million recorded in Q2 2025.
- Over the past 5 years, Denali Therapeutics' Other Gross PP&E Adjustments peaked at $12.3 million during Q4 2023, and registered a low of -$50.2 million during Q1 2025.
- For the 5-year period, Denali Therapeutics' Other Gross PP&E Adjustments averaged around -$25.1 million, with its median value being -$29.8 million (2022).
- Per our database at Business Quant, Denali Therapeutics' Other Gross PP&E Adjustments skyrocketed by 9270.96% in 2023 and then tumbled by 9834.45% in 2025.
- Quarter analysis of 5 years shows Denali Therapeutics' Other Gross PP&E Adjustments stood at $7.3 million in 2021, then dropped by 12.21% to $6.4 million in 2022, then surged by 92.71% to $12.3 million in 2023, then tumbled by 83.93% to $2.0 million in 2024, then plummeted by 2598.59% to -$49.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$49.4 million for Q3 2025, versus -$47.4 million for Q2 2025 and -$50.2 million for Q1 2025.